Paper1623482
Cell kinetics of medulloblastomas.
Ito S and 3 others. Cancer, 1992. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Cell kinetics of medulloblastomas. Papers, record 1623482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1623482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebellar Neoplasms | Major topic |
| Medulloblastoma | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Adolescent | |
| Adult | |
| Autoradiography | |
| Bromodeoxyuridine | |
| Child | |
| Child, Preschool | |
| Female | |
| Humans | |
| Idoxuridine | |
| Immunoenzyme Techniques | |
| Infant | |
| Male | |
| S Phase | |
| Survival Analysis |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 13525 | NCI NIH HHS | United States | P01CA013525 | PubMed and NIH | NIH RePORTER |
| CA 50210 | NCI NIH HHS | United States | R01CA050210 | PubMed and NIH | NIH RePORTER |
| P02CA013525 | NIH | NIH RePORTER |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40083391 | Radiological progression of medulloblastoma from non-existence to symptomatic mass in 42 days: Case report, kinetic analysis, and literature review. | Brain Spine | 2025 | https://conductscience.org/library/papers/40083391 | PubMed |
| 30283582 | Natural History of Medulloblastoma in a Child with Neurofibromatosis Type I. | Asian J Neurosurg | 2018 | https://conductscience.org/library/papers/30283582 | PubMed |
| 29687281 | Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis. | J Neurooncol | 2018 | https://conductscience.org/library/papers/29687281 | PubMed |
| 29577351 | A New Way to Treat Brain Tumors: Targeting Proteins Coded by Microcephaly Genes?: Brain tumors and microcephaly arise from opposing derangements regulating progenitor growth. Drivers of microcephaly could be attractive brain tumor targets. | Bioessays | 2018 | https://conductscience.org/library/papers/29577351 | PubMed |
| 25475127 | DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiation. | World J Surg Oncol | 2014 | https://conductscience.org/library/papers/25475127 | PubMed |
| 19139904 | Medulloblastoma: clinicopathologic evaluation of 42 pediatric cases. | Childs Nerv Syst | 2009 | https://conductscience.org/library/papers/19139904 | PubMed |
| 17187666 | Kinetic modeling of tumor growth and dissemination in the craniospinal axis: implications for craniospinal irradiation. | Radiat Oncol | 2006 | https://conductscience.org/library/papers/17187666 | PubMed |
| 15682321 | Recent advances in embryonal tumours of the central nervous system. | Childs Nerv Syst | 2005 | https://conductscience.org/library/papers/15682321 | PubMed |
| 12946027 | Anaplasia and grading in medulloblastomas. | Brain Pathol | 2003 | https://conductscience.org/library/papers/12946027 | PubMed |
| 12222838 | Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. | J Neurooncol | 2002 | https://conductscience.org/library/papers/12222838 | PubMed |
| 10778725 | Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density. | J Neurooncol | 1999 | https://conductscience.org/library/papers/10778725 | PubMed |
| 8858517 | Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods. | J Neurooncol | 1996 | https://conductscience.org/library/papers/8858517 | PubMed |
| 8789396 | Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis. | Histochem J | 1995 | https://conductscience.org/library/papers/8789396 | PubMed |
| 8398711 | p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8398711 | PubMed |
| 7912469 | Tumor cell proliferation and apoptosis in medulloblastoma. | Acta Neuropathol | 1994 | https://conductscience.org/library/papers/7912469 | PubMed |
| 7815099 | Proliferative potential and prognostic evaluation of low-grade astrocytomas. | J Neurooncol | 1994 | https://conductscience.org/library/papers/7815099 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1623482
GET https://conductscience.org/api/papers/v1/1623482/authors